Clinical trials
Recruiting Carcinoma, Hepatocellular trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
259 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 9 |
| 2022 | 21 |
| 2023 | 24 |
| 2024 | 69 |
| 2025 | 72 |
| 2026 | 43 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 259 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 27 |
| Second Affiliated Hospital of Guangzhou Medical University | 16 |
| West China Hospital | 8 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 7 |
| Tianjin Medical University Cancer Institute and Hospital | 7 |
| Tongji Hospital | 7 |
| Zhongda Hospital | 7 |
| Fudan University | 6 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 5 |
| Peking Union Medical College Hospital | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 259 |
| Liver Neoplasms | 20 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Colorectal Neoplasms | 10 |
| Stomach Neoplasms | 10 |
| Melanoma | 9 |
| Ovarian Neoplasms | 9 |
| Pancreatic Neoplasms | 9 |
| Cholangiocarcinoma | 7 |
| Lung Neoplasms | 7 |
Trials
Showing 1 to 25 of 259. Each trial links to its page on Pharma Observatory.
159 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.